N-Acetyl Cysteine için Depression-Related Cognitive Dysfunction

Research suggests NAC's glutamate modulation and glutathione restoration may help address cognitive aspects of depression. Evidence is emerging from several clinical studies exploring NAC as an adjunctive treatment.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Ddepression\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Sonuç

Key Study Findings

Review

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: restless legs syndrome

Review

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

Other n=24 2 weeks

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging.

Dose: NAC 100 mg/kg body weight orally daily for 14 days vs: Placebo Etki: significant augmentation of antioxidants and reduction of prooxidants in old rats; downregulation of None

Review

Restless legs syndrome.

Dose: None vs: None Outcome: quality of life Etki: None None

Popülasyon: cardiovascular patients

In Vitro

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.

Dose: Valerian extract and valerenic acid vs: LSD binding Outcome: 5-HT5a receptor binding affinity Etki: PE extract IC50 15.7 ng/ml (high affinity) None

Popülasyon: None

Key Statistics

Çalışmalar

400

Katılımcılar

↑

Positive

Derece

Referenced Papers

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. Review

Sleep medicine clinics 2021 14 atıf

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Review

Neuroscience and biobehavioral … 2019 45 atıf

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging. Other

Canadian journal of … 2018 37 atıf

Restless legs syndrome. Review

Handbook of clinical … 2011 8 atıf

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Other

Brain research. Molecular … 2005 160 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:: 600-1,800 mg/day
neuroprotection:: 1,200-2,400 mg/day

Üst sınır: Not established as supplement; 6,000+ mg/day used clinically (IV)

Araştırmalarda İncelenen Dozajlar

Dozaj	Süre	Etki	N
None	--	Mixed	--
None	--	Positive	--
NAC 100 mg/kg body weight orally daily for 14 days	2 weeks	Positive	24
None	--	Mixed	--
Valerian extract and valerenic acid	--	Positive	--

En iyi alım zamanı: On empty stomach; split into 2-3 doses; supplement zinc if using long-term

Safety & Side Effects

Bildirilen Yan Etkiler

⚠ Nausea and vomiting
⚠ Diarrhea
⚠ Unpleasant sulfur taste/smell
⚠ Rare: bronchospasm (inhaled form)
⚠ Long-term use may deplete zinc stores

Bilinen Etkileşimler

● Nitroglycerin (may enhance hypotensive effects)
● Activated charcoal (reduces NAC absorption)
● Anticoagulants (theoretical interaction)

Tolere edilebilir üst alım: Not established as supplement; 6,000+ mg/day used clinically (IV)

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does N-Acetyl Cysteine help with Depression-Related Cognitive Dysfunction?

Based on 6 studies with 400 participants, there is limited but promising evidence that N-Acetyl Cysteine may support Depression-Related Cognitive Dysfunction management. Our evidence grade is C (Some Evidence).

How much N-Acetyl Cysteine should I take for Depression-Related Cognitive Dysfunction?

Studies have used various dosages. A commonly studied range is 600-1,800 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of N-Acetyl Cysteine?

Reported side effects may include Nausea and vomiting, Diarrhea, Unpleasant sulfur taste/smell, Rare: bronchospasm (inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for N-Acetyl Cysteine and Depression-Related Cognitive Dysfunction?

We rate the evidence as Grade C (Some Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Şu durum için diğer içerikler: Depression-Related Cognitive Dysfunction

Omega-3 Fatty Acids (DHA/EPA) B Vitamin D C

N-Acetyl Cysteine diğer sağlık durumları için

Oxidative Stress & Neuroinflammation B Post-Concussion Cognitive Symptoms B

Hızlı Değerlendirme

Evidence Strength52%

Moderate confidence

Çalışma Dağılımı

RCT (0)Meta (0)Other (6)

Alternatifleri Karşılaştır

Bu durum için diğer bileşenlerin nasıl karşılaştırıldığını görün.Diğer içeriklerin bu sağlık durumu için nasıl karşılaştırıldığını görün.

Şu durum için tüm içerikleri görüntüle: Depression-Related Cognitive Dysfunction

Daha Fazla Bilgi

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.